Abstract
The Raf/MEK/MAP kinase cascade plays a critical role in transducing growth signals from activated cell surface receptors. Using ΔMEK1:ER, a conditionally active form of MEK1, we demonstrate the ability of this dual specificity protein kinase to abrogate the cytokine dependency of the murine lymphoid hematopoietic cell line FL5.12. Cytokine-independent cells were obtained from FL5.12 cells at a frequency of 1 × 10−7, indicating that a low frequency of cells expressing ΔMEK1:ER were factor-independent. In general, cells that were converted to a cytokine-independent phenotype displayed a higher level of MAP kinase activity in response to ΔMEK1:ER activation than those that remained cytokine-dependent. ΔMEK1:ER-responsive cells could be maintained long-term in the presence of β-estradiol, as well as the estrogen-receptor antagonist 4-hydroxy-tamoxifen. Removal of hormone led to the rapid cessation of cell growth in a manner similar to that observed when cytokine is withdrawn from the parental cells. GM-CSF mRNA transcripts were detected in the MEK1-responsive cells indicating that activated ΔMEK1:ER may induce a pathway leading to autocrine proliferation. Cytokine-dependent ΔMEK1:ER cells were found to increase the expression of GM-CSF receptor α (GM-CSFRα) in response to β-estradiol. In contrast, MEK1-responsive cells were found to express constitutively lower levels of GM-CSFRα and β common (βc) chains indicating that constitutive GM-CSF expression resulted in a decrease in GM-CSFR expression. Treatment of parental cells with supernatant from MEK1-responsive FL5.12 cells was sufficient to promote [3H]-thymidine incorporation. GM-CSF was found to enhance the viability of FL5.12 cells. The cell lines described here will be useful for elaborating the ability of the MAP kinase pathway to regulate cell proliferation in hematopoietic cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arai K-I, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T . Cytokines: coordinators of immune and inflammatory responses Annu Rev Biochem 1990 59: 783–836
Wang XY, McCubrey JA . Regulation of interleukin-3 expression in normal and autocrine transformed hematopoietic cells Int J Oncol 1997 10: 989–1001
Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang X-Y, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA . Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs Leukemia 1999 13: 1109–1166
Dexter TM, Garland J, Scott D, Scolnick E, Metcalf D . Growth of factor-dependent hematopoietic precursor cell lines J Exp Med 1980 152: 1036–1047
McKearn JP, McCubrey JA, Fagg B . Enrichment of hematopoietic precursor cells and cloning of B-lymphocyte precursors Proc Natl Acad Sci USA 1985 82: 7414–7418
Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F . Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin J Cell Physiol 1989 140: 323–334
McCubrey JA, Holland G, McKearn J, Risser R . Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms Oncogene Res 1989 4: 97–109
McCubrey JA, Steelman LS, Hoyle PA, Blalock WL, Weinstein-Oppenheimer CR, Franklin RA, Cherwinski H, Bosch E, McMahon M . Differential abilities of activated Raf oncoproteins to abrogate cytokine-dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells Leukemia 1998 12: 1903–1929
McCubrey JA, Smith SR, Algate PA, de Vente JE, White MK, Steelman LS . Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene Oncogene 1993 8: 2905–2915
Mayo MW, Steelman LS, McCubrey JA . Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-Jun expression Oncogene 1994 9: 1999–2008
Wang XY, McCubrey JA . Malignant transformation induced by cytokine genes: a comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and post-transcriptional mechanisms Cell Growth Differ 1996 7: 487–500
Wang XY, McCubrey JA . Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation Leukemia 1997 11: 1711–1725
McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA, Kaleko M . Growth promoting effects of insulin-like growth factor-1 on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates IL-3-dependency of murine factor dependent cells by a ligand-dependent mechanism Blood 1991 78: 921–929
Wang X-Y, Hoyle PE, McCubrey JA . Characterization of proteins binding specifically to the interleukin 3 (IL-3) mRNA 3′ untranslated region in IL-3-dependent and autocrine transformed cells Leukemia 1998 12: 520–531
Kitamura T, Sato M, Arai K-I, Miyajima A . Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit of the human IL-3 and GM-CSF receptors Cell 1991 66: 1165–1174
Miyajima A, Kitamura T, Harada N, Yokota T, Arai K-I . Cytokine receptors and signal transduction Annu Rev Immunol 1992 10: 295–331
Algate PA, Steelman LS, Mayo MW, Miyajima A, McCubrey JA . Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line Blood 1994 83: 2450–2468
Ihle JN, Witthuhn BA, Quell FW, Yamamoto K, Silvennoinen O . Signaling through the hematopoietic cytokine receptors Annu Rev Immunol 1995 13: 369–399
Kinoshita T, Yokota T, Arai K-I, Miyajima A . Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors EMBO J 1995 14: 266–275
Steelman LS, Algate PA, Blalock WL, Wang XY, Prevost KD, Hoyle PE, McCubrey JA . Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells Leukemia 1996 10: 528–542
Yoshimura A . The CIS/JAB family; novel negative regulators of JAK signaling pathways Leukemia 1998 12: 1851–1857
Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y, Hirai H . The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells J Biol Chem 1995 270: 10800–10805
Odai H, Sasaki K, Iwamatsu A, Nakamoto T, Ueno H, Yamagata T, Mitani K, Yazaki Y, Hirai H . Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin and Bcr-Abl Blood 1997 89: 2745–2756
Odai H, Hanazono Y, Sasaki K, Iwamatu A, Yazaki Y, Hirai H . The signal transduction through Grb2/Ash in hematopoietic cells Leukemia 1997 11: (Suppl. 3) 405–407
Hanazono Y, Odai H, Sasaki K, Iwamatsu A, Yazaki Y, Hirai H . Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells Acta Haematol 1996 95: 236–242
Anderson SM, Burton EA, Koch BL . Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn and phosphatidylinositol 3-kinase J Biol Chem 1997 272: 739–745
Mufson RA . The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction FASEB J 1997 11: 37–44
Dent P, Wu J, Romero G, Vincent LA, Castle D, Sturgill TW . Activaiton of the mitogen-activated protein kinase pathway in Triton X-100 disrupted NIH-3T3 cells by p21 ras and in vitro by plasma membranes from NIH-3T3 cells Mol Cell Biol 1993 4: 483–493
Dent P, Chow YH, Wu J, Morrison DK, Jove R, Sturgill TW . Expression, purification and characterization of recombinant mitogen-activated protein kinase kinases Biochem J 1994 303: 105–112
Dent P, Reardon DB, Morrison DK, Sturgill TW . Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro Mol Cell Biol 1995 15: 4125–4135
Jelinek T, Dent P, Sturgill TW, Weber MJ . Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation Mol Cell Biol 1996 16: 1027–1034
Stancato LF, Sakatsume M, David M, Dent P, Dong F, Petricoin EF, Krolewski JJ, Silvennoinen O, Saharinen P, Pierce J, Marshall CJ, Sturgill T, Finbloom DS, Larner AC . Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway Mol Cell Biol 1997 17: 3833–3840
Stancato LF, Yu CR, Petricoin EF III, Larner AC . Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat 1 transcription factor J Biol Chem 1998 273: 18701–18704
Sakatsume M, Stancato LF, David M, Silvennoinen O, Saharinen P, Pierce J, Larner AC, Finbloom DS . Interferon gamma activation of Raf-1 is Jak 1-dependent and p21 ras-independent J Biol Chem 1998 273: 3021–3026
Herrera R, Hubbell S, Decker S, Petruzzelli L . A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells Exp Cell Res 1998 238: 407–414
Shelly C, Petruzzelli L, Herrera R . PMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events Leukemia 1998 12: 1951–1961
Dent P, Jarvis WD, Birrer MJ, Fisher PB, Schmidt-Ullrich RK, Grant S . The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio-and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity Leukemia 1998 12: 1843–1850
Cowley S, Patterson H, Kemp P, Marshall CJ . Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells Cell 1994 77: 841–852
Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG . Transformation of mammalian cells by constitutively active MAP kinase kinase Science 1994 265: 966–970
Huang W, Kessler DS, Erikson RL . Biochemical and biological analysis of MEK1 phosphorylation site mutants Mol Cell Biol 1995 15: 237–245
Brunet A, Pages G, Pouyssegur J . Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts Oncogene 1994 9: 3379–3387
Davis RJ . Transcriptional regulation by MAP kinases Mol Repro Dev 1995 42: 459–467
Thompson CB, Gajewski TF . Apoptosis meets signal transduction: elimination of a Bad influence Cell 1996 87: 589–592
Yang E, Jiping Z, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ . Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death Cell 1995 80: 285–291
Wang H-G, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Lawrence Hovey I, Troppmair J, Rapp UR, Reed JC . Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase Oncogene 1994 9: 2751–2756
Wang HG, Rapp UR, Reed JC . Bcl-2 targets the protein kinase Raf-1 to mitochondria Cell 1996 87: 629–638
Reed JC, Wang HG, Takayama S, Rapp UR . Bcl-2 interacting protein, Bag-1, binds to and activates the kinase Raf-1 Proc Natl Acad Sci USA 1996 93: 7063–7068
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ . Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14–3-3 not Bcl-xL Cell 1996 87: 619–628
May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA, Davidson NE . Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis J Biol Chem 1994 269: 26865–26870
Rinaudo MS, Su K, Falk LA, Halder S, Mufson RA . Human interleukin-3 receptor modulates Bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells Blood 1995 86: 80–88
del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt Science 1997 278: 687–689
Ito T, Deng X, Carr B, May WS . Bcl-2 phosphorylation required for anti-apoptosis function J Biol Chem 1997 272: 11671–11673
Deng X, Ito T, Carr B, Mumby M, May WS . Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A J Biol Chem 1998 273: 34157–34163.
Gubina E, Rinaudo MS, Szallasi Z, Blumberg PM, Mufson RA . Overexpression of protein kinase C isoform epsilon, but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression Blood 1998 91: 823–829
Cleveland JL, Troppmair J, Packham G, Askew DS, Lloyd P, Gonzalez-Garcia M, Nunez G, Ihle JN, Rapp UR . v-Raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells Oncogene 1994 9: 2227–2234
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 1995 270: 1326–1331
Perkins GR, Marshall CJ, Collins MKL . The role of MAP kinase in interleukin-3 stimulation of proliferation Blood 1996 87: 3669–3675
Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H, McMahon M, McCubrey JA . A conditionally active form of MEK1 abrogates cytokine dependency in human and mouse hematopoietic cells Oncogene 2000 19: 526–536
Bosch E, Cherwinski H, Peterson D, McMahon M . Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 Oncogene 1997 11: 1021–1034
Morgenstern JP, Land H . Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line Nucleic Acids Res 1990 18: 3587–3596
Samuels ML, Weber MJ, Bishop JM, McMahon M . Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase Mol Cell Biol 1993 13: 6241–6252
Pritchard CA, Samuels ML, Bosch E, McMahon M . Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH-3T3 cells Mol Cell Biol 1995 15: 9430–9442
Aziz N, Cherwinski H, McMahon M . Complementation of defective colony-stimulating factor 1 signaling and mitogenesis by Raf and v-Src Mol Cell Biol 1999 19: 1101–1115
McCubrey JA, Steelman LS, Wang XY, Davidian EW, Hoyle PE, White CR, Prevost KD, Algate PA, Robbins P, Mylott D, White MK . Autocrine growth factor secretion after transformation of human cytokine-dependent cells by viral and cellular oncogenes Int J Oncol 1995 7: 573–586
Rapp UR, Kerkhoff E . Induction of cell proliferation in quiescent NIH3T3 cells by oncogenic c-Raf-1 Mol Cell Biol 1997 17: 2576–2586
Acknowledgements
We appreciate the artwork done by Ms Catherine Spruill and the staff of the ECU Center for Medical Communications. This work was supported in part by grants from the NCI (R01CA51025), the North Carolina Biotechnology Center (9805-ARG-0006) (JAM). RAF was supported in part by grants from the American Cancer Society (IRG-97-149), the American Heart Association (9930099N) and the North Carolina Biotechnology Center (9705-ARG-0009).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blalock, W., Pearce, M., Chang, F. et al. Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells. Leukemia 15, 794–807 (2001). https://doi.org/10.1038/sj.leu.2402109
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402109
Keywords
This article is cited by
-
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
Leukemia (2011)
-
Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo
Apoptosis (2011)
-
Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
Immunologic Research (2011)
-
Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors
Leukemia (2005)
-
Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell support
Leukemia (2005)